174 related articles for article (PubMed ID: 31273243)
1. Elastolytic activity of cysteine cathepsins K, S, and V promotes vascular calcification.
Andrault PM; Panwar P; Mackenzie NCW; Brömme D
Sci Rep; 2019 Jul; 9(1):9682. PubMed ID: 31273243
[TBL] [Abstract][Full Text] [Related]
2. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.
Aikawa E; Aikawa M; Libby P; Figueiredo JL; Rusanescu G; Iwamoto Y; Fukuda D; Kohler RH; Shi GP; Jaffer FA; Weissleder R
Circulation; 2009 Apr; 119(13):1785-94. PubMed ID: 19307473
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen Sulfide Prevents Elastin Loss and Attenuates Calcification Induced by High Glucose in Smooth Muscle Cells through Suppression of Stat3/Cathepsin S Signaling Pathway.
Zhou YB; Zhou H; Li L; Kang Y; Cao X; Wu ZY; Ding L; Sethi G; Bian JS
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461977
[TBL] [Abstract][Full Text] [Related]
4. Expression of elastolytic cathepsins in human skin and their involvement in age-dependent elastin degradation.
Panwar P; Hedtke T; Heinz A; Andrault PM; Hoehenwarter W; Granville DJ; Schmelzer CEH; Brömme D
Biochim Biophys Acta Gen Subj; 2020 May; 1864(5):129544. PubMed ID: 32007579
[TBL] [Abstract][Full Text] [Related]
5. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.
Sukhova GK; Shi GP; Simon DI; Chapman HA; Libby P
J Clin Invest; 1998 Aug; 102(3):576-83. PubMed ID: 9691094
[TBL] [Abstract][Full Text] [Related]
6. Elastin degradation by cathepsin V requires two exosites.
Du X; Chen NL; Wong A; Craik CS; Brömme D
J Biol Chem; 2013 Nov; 288(48):34871-81. PubMed ID: 24121514
[TBL] [Abstract][Full Text] [Related]
7. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.
Cheng XW; Kuzuya M; Nakamura K; Di Q; Liu Z; Sasaki T; Kanda S; Jin H; Shi GP; Murohara T; Yokota M; Iguchi A
Am J Pathol; 2006 Feb; 168(2):685-94. PubMed ID: 16436681
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.
Yasuda Y; Li Z; Greenbaum D; Bogyo M; Weber E; Brömme D
J Biol Chem; 2004 Aug; 279(35):36761-70. PubMed ID: 15192101
[TBL] [Abstract][Full Text] [Related]
9. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors.
Novinec M; Grass RN; Stark WJ; Turk V; Baici A; Lenarcic B
J Biol Chem; 2007 Mar; 282(11):7893-902. PubMed ID: 17227755
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cathepsin S exosites that govern its elastolytic activity.
Andrault PM; Panwar P; Brömme D
Biochem J; 2020 Jan; 477(1):227-242. PubMed ID: 31860022
[TBL] [Abstract][Full Text] [Related]
11. Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation.
Petsophonsakul P; Furmanik M; Forsythe R; Dweck M; Schurink GW; Natour E; Reutelingsperger C; Jacobs M; Mees B; Schurgers L
Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1351-1368. PubMed ID: 31144989
[TBL] [Abstract][Full Text] [Related]
12. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.
Jaffer FA; Kim DE; Quinti L; Tung CH; Aikawa E; Pande AN; Kohler RH; Shi GP; Libby P; Weissleder R
Circulation; 2007 May; 115(17):2292-8. PubMed ID: 17420353
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP
Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K-targeted sub-micron particles for regenerative repair of vascular elastic matrix.
Jennewine B; Fox J; Ramamurthi A
Acta Biomater; 2017 Apr; 52():60-73. PubMed ID: 28087488
[TBL] [Abstract][Full Text] [Related]
16. Matrilysin-dependent elastolysis by human macrophages.
Filippov S; Caras I; Murray R; Matrisian LM; Chapman HA; Shapiro S; Weiss SJ
J Exp Med; 2003 Sep; 198(6):925-35. PubMed ID: 12963695
[TBL] [Abstract][Full Text] [Related]
17. Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells.
Hosaka N; Mizobuchi M; Ogata H; Kumata C; Kondo F; Koiwa F; Kinugasa E; Akizawa T
Calcif Tissue Int; 2009 Dec; 85(6):523-9. PubMed ID: 19806384
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin S cannibalism of cathepsin K as a mechanism to reduce type I collagen degradation.
Barry ZT; Platt MO
J Biol Chem; 2012 Aug; 287(33):27723-30. PubMed ID: 22730330
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate vein graft neointimal hyperplasia.
Shi HT; Wang Y; Jia LX; Qin YW; Liu Y; Li HH; Qi YF; Du J
Cardiovasc Res; 2014 Mar; 101(3):454-63. PubMed ID: 24319016
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification.
Jover E; Silvente A; Marín F; Martínez-González J; Orriols M; Martinez CM; Puche CM; Valdés M; Rodriguez C; Hernández-Romero D
FASEB J; 2018 Aug; 32(8):4459-4469. PubMed ID: 29547702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]